Article 1 to 3 out of 3 concerning Raptor Pharmaceutical Inc.
Raptor Pharmaceuticals Enters Collaboration Agreement with UC San Diego in Liver Disease(21 Jul 2008) Raptor to Support Phase 2a Clinical Trial at UCSD Raptor Pharmaceuticals Corp. announced the execution of a collaboration agreement with the University of California, San Diego ("UCSD") to include a Phase 2a clinical trial to evaluate a delayed-release preparation of cysteamine bitartrate in ...
Raptor Pharmaceuticals Expands Board of Directors and Scientific Advisory Board(17 Jul 2008) Raptor Pharmaceuticals Corp. announced the appointments of Richard L. Franklin, M.D., Ph.D. to the Company's board of directors and Stephen C. Blacklow, M.D., Ph.D. to its scientific advisory board.Dr. Franklin has 25 years of experience in the ...
Raptor Pharmaceuticals Corp. Enters Agreements to Advance Clinical Pipeline(25 Mar 2008) Acquires Rights from UCSD to Develop Cysteamine for the Treatment of NASH Raptor Pharmaceuticals Corp. announced that its clinical development subsidiary, Bennu Pharmaceuticals Inc., has acquired an exclusive worldwide license to intellectual property from the University of California, San Diego ("UCSD") around the use of ...
Top
